Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Originally developed for neurodegenerative diseases like Alzheimers, Dihexa is now emerging as a cornerstone of modern anti-aging therapy
This makes combination therapy particularly attractive in resistant cases or where long-term results are needed
Lawrie SM, Whalley HC, Abukmeil SS, Kestelman JN, Donnelly L, Miller P et al (2001)
In some embodiments, the formulations described herein have a pH and/or practical osmolarity as described herein, and have a concentration of active pharmaceutical ingredient from about 0.0001% to about 60%, from about 0.001% to about 40%, from about 0.01% to about 20%, from about 0.01% to about 10%, from about 0.01% to about 7.5%, from about 0.01% to about 6%, from about 0.01 to about 5%, from about 0.1 to about 10%, or from about 0.1 to about 6% of the active ingredient by weight of the formulation
Thats a disorder that affects how the brain develops
Key implications Study protocols must justify the relevance of each patient-reported outcome (PRO)
